ArticleOpen access emergency medicine : OAEM2026
Diagnostic Value of D-Dimer in Patients Visiting the Emergency Department with Symptoms of Acute Coronary Syndrome: A Retrospective Observational Study.
Article in Open access emergency medicine : OAEM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: D-dimer is a fibrin degradation product formed during fibrinolysis and reflects the activation of coagulation and fibrinolytic pathways. The role of D-dimer in acute coronary syndrome (ACS) remains uncertain. This study was designed to analyse differences in D-dimer levels in patients with different forms of ACS and the diagnostic efficiency and possible complementary role of the D-dimer biomarker. Methods: This study applied a retrospective observational design and included adult patients presenting to the emergency department with chest pain. Differences in D-dimer levels across diagnostic categories were analysed. To evaluate the diagnostic performance of D-dimer, receiver operating characteristic (ROC) analysis was conducted, which involved calculations of area under the curve (AUC), sensitivity, specificity, and likelihood ratios. Also, the incremental value of D-dimer over clinical data and cardiac troponin was determined through a multivariate logistic regression model. Results: The study found that the level of D-dimer was significantly higher in patients with ST elevation myocardial infarction (STEMI) and Non-ST elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) and non-specific chest pain (p < 0.001). As per ROC analysis, the level of D-dimer demonstrated modest discrimination between STEMI/NSTEMI and unstable angina (AUC 0.618; 95% CI 0.538-0.697), and a fair discrimination between STEMI/NSTEMI and non-specific chest pain (AUC 0.668; 95% CI 0.601-0.736). At a cutoff of 0.50 mg/L, sensitivity and specificity were limited. In multivariable models, D-dimer did not provide incremental diagnostic value beyond clinical variables and cardiac troponin (ΔAUC not significant). Conclusion: Despite higher D-dimer concentrations in myocardial infarction, the marker exhibited modest diagnostic performance and did not provide additional diagnostic value over cardiac troponin. Therefore, D-dimer is suggested to be used as an adjunct rather than primary diagnostic instrument in patients presenting with suspected acute coronary syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.